Novo Says May Take Years to Comply With FDA Request

Feb. 11 (Bloomberg) -- Novo Nordisk A/S Chief Executive Officer Lars Rebien Soerensen discusses the U.S. Food and Drug Administration's decision not to approve the insulin maker's Tresiba diabetes treatment, saying more data on heart safety is needed. He talks from Copenhagen with Francine Lacqua on Bloomberg Television's "On the Move." (Source: Bloomberg)
Mr. Lee Is Singapore and Singapore Reflects Mr. Lee: Ong
25:56 - RSIS Executive Deputy Chairman Ong Keng Yong discusses the impact Lee Kuan Yew had on Singapore, its people and its neighbors with Bloomberg’s Haslinda Amin on “First Up.” (Source: Bloomberg)
  • Kleiner Perkins Attorney Speaks on Pao Suit Verdict
  • Kleiner's Not Guilty in Pao Case - Bloomerg West (03/27)
  • Sanford Says Pao Case Shows `Fundamental Problem'